Market Place
Sourcing Support
Top Pharma & Biotech Deals, Investments, M&As – July 2018
July may not have seen any big-ticket deals — i.e. deals in excess of US$ 1 billion — in
FDA to strengthen drug manufacturing inspections; A person of Indian origin to head Novartis
This week in Phispers, we introduce you to Vas Narasimhan, the new CEO set to head Novartis in Febru
Sanofi lawsuit highlights Mylan’s unfair trade practices; Fresenius goes on multi-billion dollar spending spree
This week, Phispers brings you an update on M&As in the drug and medical equipment industry, alo
Singh bros hit back at Daiichi in Ranbaxy case; New drug shortages legislation in Canada
This
week, Phispers brings you the latest twist in the Singh brothers-Daiichi 2008
Ranbaxy sell-off
US introduces bills to let FDA recall unsafe drugs, allow drug imports from Canada
In Phispers this week, we bring you news on two new bills in the US that seek to bring in cheaper me
Will a Spanish drug, retailing for under 10 euros, get sold in the U.S. for $89,000/year?
On
February 9, 2017 Marathon Pharmaceuticals LLC received FDA approval for Emflaza
(deflazacort), ta
